Ability Biologics Announces Closing of Its US$18 Million Seed Funding Expansion Towards the Generation of Novel, Highly Targeted Immunomodulators
MONTREAL, June 18, 2024 /PRNewswire/ – Ability Biologics (“Ability”) announced the final close of its seed funding, raising a total […]